A blog about the intersection of medicine and business, produced by the members of the Medical Consumerism seminar at the University of Minnesota.
Tuesday, January 19, 2010
The Johnson & Johnson PR Blunder
Public relations textbooks cite the way Johnson & Johnson handled the Tylenol poisoning scare of 1982 as an ideal way to handle bad publicity. So why is Johnson & Johnson managing its current drug problems so badly? Natasha Singer reports in the New York Times.
No comments:
Post a Comment